                         SEQUENCE LISTING

<110>  ProQR Therapeutics II B.V.
       Helvensteijn, Werner
       Yilmaz-Elis, Aliye Seda
       Platenburg, Gerardus J
 
<120>  Delivery of nucleic acids for the treatment of auditory disorders

<130>  P3718PC00

<150>  EP 19181770.9
<151>  2019-06-21

<150>  EP 19200251.7
<151>  2019-09-27

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Antisense oligonucleotide mQR-421a

<400>  1
aacucuggag gaauuuaaau c                                                 21


<210>  2
<211>  21
<212>  RNA
<213>  Artificial sequence

<220>
<223>  Antisense oligonucleotide

<400>  2
cguucuccag gaaagccgau g                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  mUSH2a-exon11-Fw1 primer

<400>  3
gaccgtggat ggagacatta c                                                 21


<210>  4
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  mUSH2a-exon13-Rv1 primer

<400>  4
gcattgctgg gagaactgta                                                   20


<210>  5
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  mUSH2a-exon11-P1 ddPCR primer

<400>  5
cagtgctcgt gcaaagcgaa tgtt                                              24


<210>  6
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  MALAT1 gapmer

<400>  6
gtcacaatgc attcta                                                       16


<210>  7
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  POU4F3-1 gapmer

<400>  7
cgctgctcaa aagtat                                                       16


<210>  8
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  POU4F3-2 gapmer

<400>  8
tcatggtatg gtaggt                                                       16


<210>  9
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  POU4F3-3 gapmer

<400>  9
aagaattcag gcgcag                                                       16


<210>  10
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Control gapmer

<400>  10
aacacgtcta tacgc                                                        15


<210>  11
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Control oligonucleotide

<400>  11
agagaaugaa ucucugaauc u                                                 21


